References
Smoking and COVID-19 outcomes:
Clift AK, von Ende A, Tan PS, et al. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort. Thorax 2022;77:65-73.
Gao M, Aveyard P, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, Coupland C, Clift AK, Harrison D, Gould D, Pavord ID. Association between smoking, e-cigarette use and severe COVID-19: a cohort study. International journal of epidemiology. 2022 Feb 18.
Shi, C., Wang, L., Ye, J. et al. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis 21, 663 (2021). https://doi.org/10.1186/s12879-021-06369-0.
Taylor EH, Marson EJ, Elhadi M, Macleod KD, Yu YC, Davids R, Boden R, Overmeyer RC, Ramakrishnan R, Thomson DA, Coetzee J. Factors associated with mortality in patients with COVID‐19 admitted to intensive care: a systematic review and meta‐analysis. Anaesthesia. 2021 Sep;76(9):1224-32.
Waterpipes and COVID-19:
World Health Organization, Eastern Mediterranean Regional Office. 2020. Tobacco and waterpipe use increases the risk of COVID-19. Website: http://www.emro.who.int/tfi/know-the-truth/tobacco-and-waterpipe-users-are-at-increased-risk-of-covid-19-infection.html. Last accessed 5/3/2022.
Changing product landscape during COVID-19:
Asare S, Majmundar A, Islami F, Bandi P, Fedewa S, Westmaas LJ, Nargis N. Changes in Cigarette Sales in the United States During the COVID-19 Pandemic. Annals of Internal Medicine. 2022 Jan;175(1):141-3.
Besaratinia A, Tommasi S. The consequential impact of JUUL on youth vaping and the landscape of tobacco products: The state of play in the COVID-19 era. Prev Med Rep. 2021 Apr 20;22:101374. doi: 10.1016/j.pmedr.2021.101374. PMID: 34168950; PMCID: PMC8207461.
Tobacco company profits during COVID-19:
Chaloupka F, Drope J, Siu E, Lee, HM. Big Tobacco Continues ‘Business As Usual’ Despite Covid-19 Pandemic [Policy Brief]. 2021. Chicago IL: UIC-IHRP-Tobacconomics. https://www.tobacconomics.org/files/research/731/covid-19-and-tobacco-company-profits-policy-brief.pdf.
Tobacco company interference during COVID-19:
STOP. Monitoring Brief: Tobacco Industry responses to the COVID-19 pandemic. Edition 1: Covering the period March 20 – April 16, 2020. Available at: https://content.tobaccotactics.org/uploads/2020/04/STOP_COVID19_Monitoring_Brief_042320.pdf.
Smoking and COVID-19 outcomes:
Clift AK, von Ende A, Tan PS, et al. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort. Thorax 2022;77:65-73.
Gao M, Aveyard P, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, Coupland C, Clift AK, Harrison D, Gould D, Pavord ID. Association between smoking, e-cigarette use and severe COVID-19: a cohort study. International journal of epidemiology. 2022 Feb 18.
Shi, C., Wang, L., Ye, J. et al. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis 21, 663 (2021). https://doi.org/10.1186/s12879-021-06369-0.
Taylor EH, Marson EJ, Elhadi M, Macleod KD, Yu YC, Davids R, Boden R, Overmeyer RC, Ramakrishnan R, Thomson DA, Coetzee J. Factors associated with mortality in patients with COVID‐19 admitted to intensive care: a systematic review and meta‐analysis. Anaesthesia. 2021 Sep;76(9):1224-32.
Waterpipes and COVID-19:
World Health Organization, Eastern Mediterranean Regional Office. 2020. Tobacco and waterpipe use increases the risk of COVID-19. Website: http://www.emro.who.int/tfi/know-the-truth/tobacco-and-waterpipe-users-are-at-increased-risk-of-covid-19-infection.html. Last accessed 5/3/2022.
Changing product landscape during COVID-19:
Asare S, Majmundar A, Islami F, Bandi P, Fedewa S, Westmaas LJ, Nargis N. Changes in Cigarette Sales in the United States During the COVID-19 Pandemic. Annals of Internal Medicine. 2022 Jan;175(1):141-3.
Besaratinia A, Tommasi S. The consequential impact of JUUL on youth vaping and the landscape of tobacco products: The state of play in the COVID-19 era. Prev Med Rep. 2021 Apr 20;22:101374. doi: 10.1016/j.pmedr.2021.101374. PMID: 34168950; PMCID: PMC8207461.
Tobacco company profits during COVID-19:
Chaloupka F, Drope J, Siu E, Lee, HM. Big Tobacco Continues ‘Business As Usual’ Despite Covid-19 Pandemic [Policy Brief]. 2021. Chicago IL: UIC-IHRP-Tobacconomics. https://www.tobacconomics.org/files/research/731/covid-19-and-tobacco-company-profits-policy-brief.pdf.
Tobacco company interference during COVID-19:
STOP. Monitoring Brief: Tobacco Industry responses to the COVID-19 pandemic. Edition 1: Covering the period March 20 – April 16, 2020. Available at: https://content.tobaccotactics.org/uploads/2020/04/STOP_COVID19_Monitoring_Brief_042320.pdf.